Dahl-Jessen M, Terkelsen T, Bak R, Jensen U
Genome Res. 2025; 35(2):231-241.
PMID: 39805705
PMC: 11874742.
DOI: 10.1101/gr.278575.123.
Chakraborty S, Strachan J, Schirmeisen K, Besse L, Mercier E, Freon K
Biol Open. 2025; 13(12.
PMID: 39786922
PMC: 11708773.
DOI: 10.1242/bio.061746.
Guo P, Wang T, Wang S, Peng X, Kim D, Liu Y
Int J Mol Sci. 2024; 25(16).
PMID: 39201623
PMC: 11354415.
DOI: 10.3390/ijms25168940.
Schirmeisen K, Naiman K, Freon K, Besse L, Chakraborty S, Ait Saada A
Nucleic Acids Res. 2024; 52(14):8286-8302.
PMID: 38917328
PMC: 11317160.
DOI: 10.1093/nar/gkae526.
Shokrollahi M, Stanic M, Hundal A, Chan J, Urman D, Jordan C
Nat Struct Mol Biol. 2024; 31(9):1319-1330.
PMID: 38632359
DOI: 10.1038/s41594-024-01286-7.
CHD4 acts as a prognostic factor and drives radioresistance in HPV negative HNSCC.
Geyer F, Geyer M, Reuning U, Klapproth S, Wolff K, Nieberler M
Sci Rep. 2024; 14(1):8286.
PMID: 38594331
PMC: 11003975.
DOI: 10.1038/s41598-024-58958-z.
The power of weak, transient interactions across biology: A paradigm of emergent behavior.
Vasquez P, Walker B, Bloom K, Kolbin D, Caughman N, Freeman R
Physica D. 2024; 454.
PMID: 38274029
PMC: 10806540.
DOI: 10.1016/j.physd.2023.133866.
Proteomic characterization of the colorectal cancer response to chemoradiation and targeted therapies reveals potential therapeutic strategies.
Li Y, Wang B, Ma F, Jiang D, Wang Y, Li K
Cell Rep Med. 2023; 4(12):101311.
PMID: 38086380
PMC: 10772406.
DOI: 10.1016/j.xcrm.2023.101311.
Hypothesis: The opposing pulling forces exerted by spindle microtubules can cause sliding of chromatin layers and facilitate sister chromatid resolution.
Daban J
Front Genet. 2023; 14:1321260.
PMID: 38075677
PMC: 10704366.
DOI: 10.3389/fgene.2023.1321260.
An intronic enhancer of Cebpa regulates adipocyte differentiation and adipose tissue development via long-range loop formation.
Li X, Zeng S, Chen L, Zhang Y, Li X, Zhang B
Cell Prolif. 2023; 57(3):e13552.
PMID: 37905345
PMC: 10905358.
DOI: 10.1111/cpr.13552.
Spatial mapping of the DNA adducts in cancer.
Krieger K, Mann E, Lee K, Bolterstein E, Jebakumar D, Ittmann M
DNA Repair (Amst). 2023; 128:103529.
PMID: 37390674
PMC: 10330576.
DOI: 10.1016/j.dnarep.2023.103529.
Potential of Synthetic and Natural Compounds as Novel Histone Deacetylase Inhibitors for the Treatment of Hematological Malignancies.
Pal D, Raj K, Nandi S, Sinha S, Mishra A, Mondal A
Cancers (Basel). 2023; 15(10).
PMID: 37345145
PMC: 10216849.
DOI: 10.3390/cancers15102808.
Transmembrane nuclease NUMEN/ENDOD1 regulates DNA repair pathway choice at the nuclear periphery.
Chen B, Ge T, Jian M, Chen L, Fang Z, He Z
Nat Cell Biol. 2023; 25(7):1004-1016.
PMID: 37322289
DOI: 10.1038/s41556-023-01165-1.
A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma.
Ramos L, Truong S, Zhai B, Joshi J, Ghaidi F, Lizardo M
Clin Cancer Res. 2023; 29(17):3541-3553.
PMID: 37279093
PMC: 10472104.
DOI: 10.1158/1078-0432.CCR-22-3897.
Peripheral Biomarkers in Manifest and Premanifest Huntington's Disease.
Morena E, Romano C, Marconi M, Diamant S, Buscarinu M, Bellucci G
Int J Mol Sci. 2023; 24(7).
PMID: 37047023
PMC: 10094222.
DOI: 10.3390/ijms24076051.
[The role of the response to DNA damage in granulomatous diseases].
Fabry L, Triantafyllopoulou A
Z Rheumatol. 2022; 81(10):881-887.
PMID: 36006470
PMC: 9732071.
DOI: 10.1007/s00393-022-01260-y.
DNA damage reduces heterogeneity and coherence of chromatin motions.
Locatelli M, Lawrimore J, Lin H, Sanaullah S, Seitz C, Segall D
Proc Natl Acad Sci U S A. 2022; 119(29):e2205166119.
PMID: 35858349
PMC: 9304018.
DOI: 10.1073/pnas.2205166119.
Role of H4K16 acetylation in 53BP1 recruitment to double-strand break sites in in vitro aged cells.
Gonzalez-Bermudez L, Genesca A, Terradas M, Martin M
Biogerontology. 2022; 23(4):499-514.
PMID: 35851632
PMC: 9388460.
DOI: 10.1007/s10522-022-09979-6.
Emerging Insight Into the Role of Circadian Clock Gene BMAL1 in Cellular Senescence.
Zhang W, Xiong Y, Tao R, Panayi A, Mi B, Liu G
Front Endocrinol (Lausanne). 2022; 13:915139.
PMID: 35733785
PMC: 9207346.
DOI: 10.3389/fendo.2022.915139.
Pharmacologic Induction of BRCAness in -Proficient Cancers: Expanding PARP Inhibitor Use.
Abbotts R, Dellomo A, Rassool F
Cancers (Basel). 2022; 14(11).
PMID: 35681619
PMC: 9179544.
DOI: 10.3390/cancers14112640.